Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.

Autor: Peñuelas, Silvia1, Noé, Véronique1, Ciudad, Carlos J.1 cciudad@ub.edu
Zdroj: FEBS Journal. Feb2005, Vol. 272 Issue 3, p696-710. 15p.
Databáze: Academic Search Ultimate